John M. Gill's most recent trade in Altimmune Inc was a trade of 12,500 Common Stock, par value $0.0001 done at an average price of $4.1 . Disclosure was reported to the exchange on Dec. 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Altimmune Inc | John M. Gill | Director | Purchase of securities on an exchange or from another person at price $ 4.10 per share. | 23 Dec 2025 | 12,500 | 12,500 (0%) | 0% | 4.1 | 51,250 | Common Stock, par value $0.0001 |
| Altimmune Inc | John M. Gill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2025 | 48,800 | 48,800 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | John M. Gill | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Sep 2025 | 2,714 | 0 (0%) | 0% | 0 | Common Stock, par value $0.0001 | |
| Altimmune Inc | John M. Gill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2024 | 34,900 | 34,900 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | John Gill M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2023 | 26,100 | 26,100 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | John M. Gill | Director | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 12 Aug 2022 | 2,714 | 2,771 (0%) | 0% | 15 | 40,710 | Common Stock, par value $0.0001 |